Cambridge Trust’s Neogen NEOG Stock Holding History

Cambridge Trust’s Portfolio NEOG Stock Details NEOG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-311	Closed	-$5K	–	798
2022 Q4	$5K	Hold	311	–	–	﹤0.01%	705
2022 Q3	$4K	Hold	311	–	–	﹤0.01%	730
2022 Q2	$7K	Buy	311 +100	+47%	+$2.68K	﹤0.01%	719
2022 Q1	$6K	Hold	211	–	–	﹤0.01%	799
2021 Q4	$10K	Buy	+211	New	+$9.03K	﹤0.01%	811

Other funds holding NEOG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Luther King Capital Management (LKCM) Fort Worth, Texas $23.1B AUM 21.31% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

Cambridge Trust's NEOG Position: Q1 2023 in Review

Cambridge Trust sold out of Neogen (NEOG) in Q1 2023, closing a stake of 311 shares — an estimated $5K sold.

Cambridge Trust first reported a position in NEOG in Q4 2021 and held it in 5 quarters. The position peaked at $10K in Q4 2021. 354 funds tracked by Wall St. Rank hold NEOG as of Q1 2023.

Cambridge Trust reported no remaining Neogen position as of Q1 2023 after selling out during the quarter.
Cambridge Trust sold 311 Neogen shares in Q1 2023, an estimated $5K.
Cambridge Trust first reported a position in Neogen in Q4 2021 and held it in 5 quarters.
Cambridge Trust's Neogen position peaked at $10K in Q4 2021.
354 funds tracked by Wall St. Rank held Neogen as of Q1 2023.

Based on Cambridge Trust's 13F filing for Q1 2023, filed 12 May 2023.